Login

Exploring Global Ventures: An Interview with Marco Soriano, CEO of Soriano Group 00:10:00

Share On Facebook Share On Twitter

Marco Antonio SORIANO VII, CEO of The Soriano Group and its global subsidiaries

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Advice to Emerging Fund Managers:Principal at Colle Capital Partners|Doug Benowitz,Principal,Colle Capital Partners
00:10:00
Gene McManus: Holistic Financial Planning for a Fulfilling Life
00:10:00
Balancing Risk and Reward: Eben Maré on Absolute Return Strategies | Eben Maré - Head of Absolute Return Funds, Stanlib
00:10:00
CEO Lawrence Hutchings on Investor Confidence, Levelling Up, and Inclusivity in Retail and Real Estate | Lawrence Hutching, CEO , Capital & Regional Plc.
00:10:00
Positioning for Growth: A Conversation with Rob Henderson, CEO of Great Panther Mining
00:10:00
Investor Working Group brought together investors and venture capital companies|Gary Sheynkman,General Partner, Leyden Ventures
00:10:00
build our financial infrastructure using software|Seth Rosenberg,Investor,Greylock
00:10:00
Accelerating Renewable Transition Through Coal Plant Retirement | Eric Francia, CEO, Acen Corp.
00:10:00
Ville Kangasmuukko on Bubbleroom's IPO Plans and E-commerce Strategy | Ville Kangasmuukko, CEO, New Bubbleroom Sweden AB.
00:10:00
Understanding Dividends: Building Wealth with Regular Income | Laurel Hardy, CEO, Bespoke Wealth Management.
00:10:00
Star Diamond Corporation: Pioneering Diamond Exploration in Saskatchewan
00:10:00
Developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products|Klaus Paulini,CEO,AEterna Zentaris Inc

© 2017 - Neuhu+